Navigation Links
New Therapies Could Change Organ Transplants
Date:1/23/2008

nosuppressant drugs for two years.

Unfortunately, six other patients who received the same treatment have not been able to give up their immunosuppressive drugs. Their kidneys were not as well-matched, however.

A third study, from Australian researchers, involved a 9-year-old girl who had received an HLA-mismatched liver from a deceased male donor and who was also able to come off immunosuppressive medications.

Essentially her body did naturally what the other two studies had to induce, Smythe said. She developed a viral infection, which dropped the number of her own white blood cell counts and allowed donor white blood cells that were in her body to take over. Being a child also helped. "My guess is that this was a large graft in a small person," Smythe said.

These advances may one day indirectly alleviate the biggest problem facing the transplant field: a shortage of donors.

"We hope this will be even more important when applied to xenografts [grafting tissue from one species, such as a pig, to another, such as a human], which will increase donors," Sachs said. "We think the pig is going to be the answer to that. We have been breeding special pigs for that purpose."

More information

Learn more about organ transplantation at the United Network for Organ Sharing.



SOURCES: David H. Sachs, M.D., director, Transplantation Biology Research Center, Massachusetts General Hospital, Boston; Samuel Strober, M.D., professor, medicine, Stanford University School of Medicine, Palo Alto, Calif.; Roy Smythe, M.D., chairman, department of surgery, Texas A&M Health Science Center School of Medicine, and Scott &White, Temple, Texas; Jan. 24, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Pipeline for New Obesity Therapies is Focus of New Report
2. MIT: Stem-cell therapies for brain more complicated than thought
3. Many prostate cancer patients receive improper or mismatched therapies
4. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
5. Telomerase enzyme structure provides significant new target for anti-cancer therapies
6. Studies attribute recent increase in multiple myeloma survival to novel therapies
7. Turning Pointe Therapeutic Riding Recognized for Excellence in Providing Equine-Assisted Therapies to People with Disabilities
8. Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
9. Mayo researchers: complementary therapies help patients recover after heart surgery
10. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
11. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Therapies Could Change Organ Transplants
(Date:11/18/2014)... Dennis Thompson HealthDay ... -- An experimental antibody drug could prove effective at ... side effects with cholesterol-lowering statin medications. That,s the ... American Heart Association annual meeting in Chicago. The ... the most widely used alternative to statins, Zetia, said ...
(Date:11/18/2014)... November 18, 2014 Financing for ... on innovative financing for international development, has announced ... Membership includes six Directors: Mr. John Skibiak of ... of the Millennium Challenge Corporation, Mr. Pape Gaye ... Impact Advisors, Mr. Aron Betru of Financing for ...
(Date:11/18/2014)... A+ Secure Packaging, a leading ... supplements and more, announced today that its LaVergne ... Practices (GMP) Registration for dietary supplements and athletic ... International verifies the A+ Secure Packaging facility meets ... of its clients by demonstrating the proper methods, ...
(Date:11/18/2014)... News) -- Hispanic women who,ve had at least five children ... heart trouble than those who,ve had fewer children or none, ... by Shivani Aggarwal of Wake Forest School of Medicine analyzed ... Miami, New York City and San Diego. About 12 percent ... A type of heart trouble called ventricular diastolic dysfunction ...
(Date:11/18/2014)... MONDAY, Nov. 17, 2014 (HealthDay News) -- Until recently, insect-transmitted ... America, but it has made its way to the United ... fatal illness is typically transmitted via the bite of the ... night. And now a new study suggests that common bedbugs ... bedbug can acquire and transmit the parasite. Our next step ...
Breaking Medicine News(10 mins):Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3
... MONTREAL, Sept. 21 Presagia, provider of ... announced the release of its ADA Toolkit, which will ... FMLA (Family and Medical Leave Act) and ADA (Americans ... supplement Presagia,s Leave Management solution, which enables customers to ...
... For the past 18 months, Atlantic has been partnering ... and production of a hands-on, interactive exhibit to be installed ... create an interactive environment that would reduce the anxiety of ... James Morris, Director of Business Development. "At the onset, I ...
... , SANTA ROSA, Calif., Sept. 21 Osseon ... cement delivery needle) and Osseoflex DR (steerable and curvable bone ... for marketing and clinical use in the European Union. , ... FDA approval in the United States, and allows for the ...
... , , , ... US, Inc. ("Astellas"), in partnership with the National Science Teachers ... Chicago-area science teachers to participate in the 2009 NSTA New ... teachers to a range of tools and resources, while providing ...
... The Defense Advanced Research Projects Agency (DARPA), the research arm ... $19.5 million for an effort led by the Duke Institute ... easy-to-use diagnostic device that can reveal who is infected with ... DARPA is interested in such a device because ...
... that individuals use a variety of cues to identify their ... than their own. A new study shows that their success ... families are the same race as themselves. In ... ("Cross-cultural perceptions of facial resemblance between kin"), French and ...
Cached Medicine News:Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 2Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 3Health News:Atlantic Partners with Children's Hospital of Philadelphia to Create an Interactive & Educational Waiting Room 2Health News:Osseon Receives CE Mark 2Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 2Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 3Health News:DARPA awards Duke $19.5 million to detect viral infection before symptoms appear 2Health News:Race has little effect on people's ability to spot family resemblances 2
(Date:11/17/2014)... -- AbbVie (NYSE: ABBV ) will participate in the ... on Thursday, Nov. 20, 2014. Bill Chase , ... formal presentation on the company at 9:20 a.m. GMT (3:20 ... of the presentation will be accessible through AbbVie,s Investor Relations ... the session will be available later that day. ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... start of a Phase 2 clinical study to evaluate ... in Wilson Disease, a rare genetic disorder and designated ... process copper. "We are delighted to proceed ... as a next step in the development program for ...
(Date:11/16/2014)...  Hanger, Inc. (NYSE: HGR ) announced ... third quarter 2014 financial results and is cancelling its ... for the completion and review of its third quarter ... financial results and reschedule its conference call after the ... About Hanger, Inc. – Built on the ...
Breaking Medicine Technology:Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
... , SINGAPORE, Dec. 15 ... it has completed the previously announced acquisition of SloMedical ... ranging from tubing sets to complex devices for minimally-invasive ... set of capabilities to medical device, medical equipment, and ...
... Open enrollment is an opportune time to find the best ... 15 Through the end of the year, thousands of Nebraska ... This is when the state,s 268,000 Medicare beneficiaries get to ... in 2010. , Prescription drug coverage is a critical part ...
Cached Medicine Technology:Flextronics Completes SloMedical Acquisition 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2
Shandon Plastic Slide Boxes...
Shandon Cardboard Slide Folders...
... The new Propaq LT is the ... environment--combining the basic parameters of continuous vital ... new design, making it perfect for just ... place. , Light enough to clip on ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
Medicine Products: